# To Evaluate the Efficacy and Safety of 'NDTx-01' in Patients With ASD or SCD

> **NCT06446193** · NA · COMPLETED · sponsor: **Neudive Inc.** · enrollment: 86 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Social Communication Disorder

## Interventions

- **DEVICE:** NDTx-01
- **BEHAVIORAL:** TAU

## Key facts

- **NCT ID:** NCT06446193
- **Lead sponsor:** Neudive Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-14
- **Primary completion:** 2025-02-06
- **Final completion:** 2025-02-06
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06446193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06446193, "To Evaluate the Efficacy and Safety of 'NDTx-01' in Patients With ASD or SCD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06446193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*